Spinal Cord Gray and White Matter Imaging in Amyotrophic Lateral Sclerosis

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

This study aims to measure in vivo the spinal cord gray and white matter in patients with Amyotrophic Lateral Sclerosis and healthy persons that match the patients' age and sex using rAMIRA imaging, a novel Magnetic Resonance Imaging (MRI) method. Patients and healthy control persons prospectively undergo MRI examinations, clinical examinations including assessments of disability, and tests of muscle force using hand held dynamometry. Serum markers of neuro-axonal injury are also assessed. Examinations for patients and healthy control persons are scheduled every six months over a time span of two years.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: t
View:

• 18 years or older

• neurologist-confirmed possible, probable or definite ALS acc. to El Escorial criteria

• at baseline: able to lie in an MRI scanner for one hour

• 18 years or older

• able to lie in MRI scanner for one hour

• 18 years or older

• neurologist-confirmed Motor Neuron Disease (not ALS)

• able to lie in MRI scanner for one hour

Locations
Other Locations
Switzerland
University Hospital Basel
RECRUITING
Basel
Contact Information
Primary
Regina Schlaeger, PD Dr.
regina.schlaeger@usb.ch
0041 61 328 67 49
Backup
Janina Wendebourg, Dr.
janina.wendebourg@usb.ch
0041 61 556 57 99
Time Frame
Start Date: 2018-05-01
Estimated Completion Date: 2025-10-01
Participants
Target number of participants: 80
Treatments
Patients with Amyotrophic Lateral Sclerosis
Patients with a possible, probable, or definite diagnosis of Amyotrophic Lateral Sclerosis according to the El Escorial Criteria.
Healthy Control Persons
Healthy control persons matching the ALS patient group in sex and age
Patients with other Motor Neuron Diseases
Patients with Motor Neuron Diseases other than ALS
Sponsors
Leads: University Hospital, Basel, Switzerland

This content was sourced from clinicaltrials.gov

Similar Clinical Trials